INAF Indofarma (Persero) Tbk

19 Aug 2019 15:27 (5 hari lalu) - PT Indofarma (Persero) Tbk (INAF ) membukukan rugi bersih pada Quarter 2 2019 sebesar 24,4 miliar. Turun bila di bandingkan dengan periode yang sama di tahun 2018 yang berhasil mencetak keuntungan sebesar 253,1 juta. Dengan demikian, rugi bersih per saham setara dengan Rp 7.86 per lembar. Berikut Laporan keuangan INAF Quarter 2 2019: Account Quarter 2 2019 Last Price 2080 Share Out 3,1 B Market Cap. 6.446,5 B Balance Sheet Cash 13,8 B Total Asset 1.399,8 B S.T Debt 811,1 B L.T Debt 116,4 B Total Equity ...

15 Aug 2019 22:08 (9 hari lalu) - Berjumpa lagi dengan Siswa Mengenal Nusantara 2019, Tahun ini Indofarma bersinergi dengan PT Aneka Tambang Tbk dan PT Asuransi Jasindo (Persero) menyelenggarakan kegiatan BUMN Hadir untuk Negeri 2019 yang diadakan di Provinsi Sulawesi Tenggara. Wilayah yang menjadi sebaran kegiatan yakni Kota Kendari, Kabupaten Kolaka dan Kecamatan Pomalaa. Sederetan kegiatan yang telah dan akan diselenggarakan yakni Safari Ramadhan, Siswa Mengenal Nusantara, Upacara HUT Kemerdekaan RI, Bantuan Kebutuhan Dasar, Pasar Murah, dan Bedah Rumah. BUMN Hadir Untuk Negeri bertujuan untuk menciptakan kondisi dan mendorong agar BUMN di Indonesia dapat memberikan sumb ...

12 Aug 2019 16:24 (12 hari lalu) - Attachments:

• 20190812_INAF_Penyampaian Bukti Iklan_30641584_lamp1.pdf
• 20190812_INAF_Penyampaian Bukti Iklan_30641584_lamp2.pdf
• 20190812_INAF_Penyampaian Bukti Iklan_30641584_lamp3.pdf

08 Aug 2019 16:02 (16 hari lalu) - Attachments:

• Saham INAF Juli 2019 (1).pdf
• Saham INAF Juli 2019 (3).pdf
• Saham INAF Juli 2019 (2).pdf

08 Aug 2019 15:10 (16 hari lalu) - Attachments:

• Saham Juni 2019 (1).pdf
• Saham Juni 2019 (2).pdf
• Saham Juni 2019 (3).pdf

08 Aug 2019 14:44 (16 hari lalu) - Attachments:

• Saham Mei 2019 (1).pdf
• Saham Mei 2019 (2).pdf
• Saham Mei 2019 (3).pdf

08 Aug 2019 14:19 (16 hari lalu) - Attachments:

• Saham April 2019 (1).pdf
• Saham April 2019 (3).pdf
• Saham April 2019 (2).pdf

07 Aug 2019 16:44 (17 hari lalu) - JAKARTA - PT Indofarma Tbk (INAF) suffered a loss of Rp 24.36 billion in the first half of 2019. This is in contradiction to Indofarma’s performance in the same period last year with a net profit of Rp 253.12 million. Based on the financial statements in the first semester, this loss was caused by Indofarma's sales which were depressed 12.04% on an annual basis to Rp 368.81 billion. In this period, the majority of the company's sales of 54.50% came from prescription drugs. However, sales of prescription drugs fell by 29.31% to Rp 200.97 billion and sales of medical equipment products rose 185.50% to Rp 23.04 billion. "INAF remains optimisti ...

07 Aug 2019 10:50 (18 hari lalu) - JAKARTA. PT Indofarma Tbk (INAF) recorded a loss of Rp 24.36 billion in the first half of this year, due to lower revenue and higher tax burden. In its disclosure of information, INAF said that net sales during the first semester of this year were only Rp 368.81 billion. Whereas in the same period last year, the company recorded net sales of Rp 419.29 billion. The lower revenue caused INAF's net profit drop dramatically. In the first semester of last year, the company was still able to record a net profit of Rp 253.19 million. For information, INAF is targeting to generate a net profit of Rp 6 billion this year. This target was stated in M ...

07 Aug 2019 09:37 (18 hari lalu) - Attachments:

• LK sem 1 '19 inaf_1.pdf